Sunday, February 7, 2021

Alembic Pharma gets five observations from USFDA for Gujarat facility

As per the USFDA, a Form 483 is issued to a firm's management at the
conclusion of an inspection when an investigator has observed any
conditions that in its judgment may constitute violations of the Food
Drug and Cosmetic (FD&C) Act and related Acts.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-gets-five-observations-from-usfda-for-gujarat-facility/articleshow/80745383.cms

No comments:

Post a Comment